Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
9.39
-0.09 (-0.95%)
At close: Feb 27, 2026, 4:00 PM EST
9.40
+0.01 (0.11%)
After-hours: Feb 27, 2026, 7:00 PM EST
Ardent Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Ardent Health stock have an average target of 14.2, with a low estimate of 10 and a high estimate of 22. The average target predicts an increase of 51.22% from the current stock price of 9.39.
Analyst Consensus: Buy
* Price targets were last updated on Jan 20, 2026.
Analyst Ratings
The average analyst rating for Ardent Health stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 7 | 6 | 4 | 4 | 4 | 4 |
| Hold | 1 | 2 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +17.15% | Jan 20, 2026 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +49.09% | Dec 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | +27.80% | Dec 18, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +27.80% | Nov 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $13 | Buy | Maintains | $20 → $13 | +38.45% | Nov 18, 2025 |
Financial Forecast
Revenue This Year
6.48B
from 5.97B
Increased by 8.56%
Revenue Next Year
6.78B
from 6.48B
Increased by 4.74%
EPS This Year
0.98
from 1.58
Decreased by -38.10%
EPS Next Year
1.37
from 0.98
Increased by 40.12%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.7B | 7.2B | ||
| Avg | 6.5B | 6.8B | ||
| Low | 6.2B | 6.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 13.0% | 11.8% | ||
| Avg | 8.6% | 4.7% | ||
| Low | 3.8% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.06 | 2.00 | |
| Avg | 0.98 | 1.37 | |
| Low | 0.83 | 1.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -32.9% | 104.0% | |
| Avg | -38.1% | 40.1% | |
| Low | -47.3% | 9.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.